Inhibition of hepatic metastasis of colon carcinoma by asialo GM1--positive cells in the liver.
This study investigates the role of hepatic asialo GM1-positive cells in inhibiting hepatic metastasis of colon carcinoma (colon adenocarcinoma 38) in mice after administration of a biological response modifier, streptococcal derivative (OK432). Administration of OK432 increased the number of asialo GM1-positive cells in the liver, enhanced natural killer activity of hepatic mononuclear cells and reduced the number of hepatic metastases of colon carcinoma inoculated into the superior mesenteric vein. Administration of antiserum against asialo GM1 reduced the number of hepatic asialo GM1-positive cells, abolished natural killer activity of hepatic mononuclear cells and increased the number of hepatic metastases. In addition, administration of antiserum against asialo GM1 even after OK432 treatment also decreased the number of asialo GM1-positive cells, reduced natural killer activity of hepatic mononuclear cells and increased the number of hepatic metastases of colon carcinoma. However, administration of gadolinium chloride, which suppresses phagocytic function of Kupffer cells, did not influence the natural killer activity of hepatic mononuclear cells or the number of hepatic metastases. In vivo tumor-neutralization assay revealed that tumor growth was inhibited by the hepatic mononuclear asialo GM1-positive cells, but not by T lymphocytes or Kupffer cells after OK432 administration. These results suggest that an increased number of hepatic asialo GM1-positive cells after administration of OK432 plays an important role in protecting against metastasis of colon carcinoma in the liver.
Shiratori
Y
Y
Department of Internal Medicine (II), Faculty of Medicine, University of Tokyo, Japan.
Nakata
R
R
Okano
K
K
Komatsu
Y
Y
Shiina
S
S
Kawase
T
T
Sugimoto
T
T
Omata
M
M
Tanaka
M
M
D000818:Animals; D002277:Carcinoma / Q000473:pathology*; D003110:Colonic Neoplasms / Q000473:pathology*; D005677:G(M1) Ganglioside / Q000032:analysis*; D007155:Immunologic Factors / Q000494:pharmacology; D007694:Killer Cells, Natural / Q000276:immunology; D007728:Kupffer Cells / Q000502:physiology; D008114:Liver Neoplasms, Experimental / Q000517:prevention & control / Q000556:secondary*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D010844:Picibanil / Q000494:pharmacology / Q000627:therapeutic use
D007155:Immunologic Factors; D005677:G(M1) Ganglioside; D010844:Picibanil; C018835:asialo GM1 ganglioside